BRIEF published on 05/20/2024 at 18:05, 1 year 8 months ago Center Point Bio-Tech Signs National Distribution Agreement Distribution Agreement Center Point Bio-Tech AlphaION Veterinary Diagnostics 2024 Launch
BRIEF published on 05/20/2024 at 18:05, 1 year 8 months ago Centre Point Bio-Tech signe un accord de distribution national AlphaION Accord De Distribution Diagnostic Vétérinaire Centre Point Bio-Tech Lancement 2024
PRESS RELEASE published on 05/20/2024 at 18:00, 1 year 8 months ago Center Point Bio-Tech Signs National Distribution Agreement Center Point Bio-Tech partners with leading veterinary distributor for AlphaION Point of Care diagnostic platform commercial launch. Accelerated product development aims at market leadership in veterinary diagnostics Center Point Bio-Tech AlphaION Product Development Diagnostic Platform Veterinary Distributor
Published on 02/14/2026 at 01:00, 14 hours 7 minutes ago Orogen Royalties Announces Annual Equity Compensation Grant
Published on 02/13/2026 at 22:15, 16 hours 52 minutes ago Storm Completes Sale of Miminiska Project for $5.8M and Outlines Plans for 2026
Published on 02/13/2026 at 17:45, 21 hours 22 minutes ago Eldorado Gold Closes $2.4 Million Strategic Investment in Gemdale Gold
Published on 02/13/2026 at 14:35, 1 day ago Datametrex Received $500,000 Purchase Order For Data Centre Solutions
Published on 02/14/2026 at 06:05, 9 hours 2 minutes ago The 139th Canton Fair Promotion Conferences to Be Held in Germany and Morocco, Highlighting Targeted Industry Opportunities
Published on 02/13/2026 at 19:20, 19 hours 47 minutes ago Retail offering successfully completed and update on Euronext Growth Oslo listing
Published on 02/13/2026 at 19:01, 20 hours 6 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/13/2026 at 18:20, 20 hours 47 minutes ago GLOBAL TECHNOLOGY LEADERS LAUNCH TRUSTED TECH ALLIANCE
Published on 02/13/2026 at 18:07, 20 hours 59 minutes ago EQS-Adhoc: Delticom AG: Based on preliminary, unaudited figures for the FY 2025, full-year revenues are below the forecast, while operating EBITDA is expected to be at the upper end of the forecasted range
Published on 02/13/2026 at 18:05, 21 hours 2 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/01/2026
Published on 02/13/2026 at 18:05, 21 hours 2 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/01/2026
Published on 02/13/2026 at 17:50, 21 hours 17 minutes ago Number of shares and voting rights - January 2026 (In French only)
Published on 02/13/2026 at 17:50, 21 hours 17 minutes ago Nombre total d'actions et droits de vote - janvier 2026
